Juliana Quero Reimão (Juliana Q Reimão)

Scopus Author ID ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2016-2024
Publications (10 Years): 10

Top Venues

Pharmaceutics

Drug development research

Parasitology

Expert opinion on drug discovery

Faculdade de Medicina de Jundiaí

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Faculdade de Medicina de Jundiaí Dec 01 2015

Brazil

Professor :: Departamento de Morfologia e Patologia Básica

Publications

Luiza Tamie Hirata Diethelm, Amanda Bruno da Silva Bellini Ramos, Giovanna Braga de Lorena, Bruna Inácio Trajano, Rafael Dias do Espírito Santo, Renata Priscila Barros de Menezes, Marcus Tullius Scotti, Fabio Antonio Colombo, Marcos José Marques, Carlos Roque Duarte Correia, Juliana Quero Reimão
First Description of Marinoquinoline Derivatives' Activity against Toxoplasma gondii . Pharmaceutics 16 (2) (2024)
Amanda Bruno da Silva Bellini Ramos, Tayline Torres, Luis Felipe Cunha Dos Reis, Gabriel Carvalho Lambert, Fábio Antônio Colombo, Marcos José Marques, Juliana Quero Reimão
Assessment of nebivolol efficacy in experimental models of toxoplasmosis: insights into parasite burden reduction and neuronal protection. Parasitology research 123 (8) (2024)
Luiza Tamie Hirata Diethelm, Amanda Bruno da Silva Bellini Ramos, Giovanna Braga de Lorena, Bruna Inácio Trajano, Rafael Dias do Espírito Santo, Renata Priscila Barros de Menezes, Marcus Tullius Scotti, Fabio Antonio Colombo, Marcos José Marques, Carlos Roque Duarte Correia, Juliana Quero Reimão
First Description of Marinoquinoline Derivatives' Activity against Toxoplasma gondii . Pharmaceutics 16 (2) (2024)
Bruna Ramos Dos Santos, Amanda Bruno da Silva Bellini Ramos, Renata Priscila Barros de Menezes, Marcus Tullius Scotti, Fábio Antônio Colombo, Marcos José Marques, Juliana Quero Reimão
Anti- Toxoplasma gondii screening of MMV Pandemic Response Box and evaluation of RWJ-67657 efficacy in chronically infected mice. Parasitology (2023)
Bruna Ramos Dos Santos, Amanda Bruno da Silva Bellini Ramos, Renata Priscila Barros de Menezes, Marcus Tullius Scotti, Fábio Antônio Colombo, Marcos José Marques, Juliana Quero Reimão
Repurposing the Medicines for Malaria Venture's COVID Box to discover potent inhibitors of Toxoplasma gondii, and in vivo efficacy evaluation of almitrine bismesylate (MMV1804175) in chronically infected mice. PloS one 18 (7) (2023)
Débora Chaves Cajazeiro, Paula Pereira Marques Toledo, Natália Ferreira de Sousa, Marcus Tullius Scotti, Juliana Quero Reimão
Drug Repurposing Based on Protozoan Proteome: In Vitro Evaluation of In Silico Screened Compounds against Toxoplasma gondii . Pharmaceutics 14 (8) (2022)
Juliana Quero Reimão, Débora P Pita Pedro, Adriano Cappellazzo Coelho
The preclinical discovery and development of oral miltefosine for the treatment of visceral leishmaniasis: a case history. Expert opinion on drug discovery 15 (6) (2020)
Juliana Quero Reimão, Elizabeth Magiolo Coser, Monica Ran Lee, Adriano Cappellazzo Coelho
Laboratory Diagnosis of Cutaneous and Visceral Leishmaniasis: Current and Future Methods. Microorganisms 8 (11) (2020)
Juliana Tonini Mesquita, Maiara Maria Romanelli, Cristiana de Melo Trinconi Trinconi Cm, Juliana Mariotti Guerra, Noemi Nosomi Taniwaki, Silvia Reni Bortolin Uliana, Juliana Quero Reimão, Andre Gustavo Tempone
Repurposing topical triclosan for cutaneous leishmaniasis: Preclinical efficacy in a murine Leishmania (L.) amazonensis model. Drug development research (2020)
Juliana Quero Reimão, Juliana Tonini Mesquita, Daiane Dias Ferreira, Andre Gustavo Tempone
Investigation of Calcium Channel Blockers as Antiprotozoal Agents and Their Interference in the Metabolism of Leishmania (L.) infantum. Evidence-based complementary and alternative medicine : eCAM 2016 (2016)

Juliana Quero Reimão.css-eqlu8i{font-size:small;padding-left:4px;} (Juliana Q Reimão)

Publication Activity (10 Years)

Top Topics

Top Venues

Juliana Quero Reimão (Juliana Q Reimão)